Verified batches produced under ISO9001 and strict synthetic quality checkpoints. Integrated HPLC-UV and Mass Spectrometry validation provided per lot.
A rigorous examination of Ligandrol (4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile), detailing chemical kinetics, binding affinity, and synthesis controls.
| Molecular Metric | Specification Parameter | Testing Methodology | Significance for Global Formulators |
|---|---|---|---|
| IUPAC Nomenclature | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile | IUPAC Standard / NMR Structural Confirmation | Guarantees exact enantiomeric conformation avoiding inactive isomers. |
| CAS Number | 1165910-22-4 | Chemical Inventory Tracking | Regulatory cross-border clearing identifier across EU, APAC, and Americas. |
| Molecular Formula & Weight | C14H12F6N2O | 338.25 g/mol | High-Resolution Mass Spectrometry (HRMS) | Exact monoisotopic mass validation to avoid micro-adulteration. |
| Assay Purity (HPLC) | ≥ 99.00% (Area Normalization) | Reverse-Phase HPLC (C18 Column, UV @ 254nm) | Ensures elimination of toxic precursors like 2-(trifluoromethyl)benzonitrile. |
| Residual Solvents | Dichloromethane < 600 ppm, Methanol < 3000 ppm | Headspace Gas Chromatography (HS-GC-FID) | Complies with ICH Q3C Guidelines for residual organic volatile matters. |
| Heavy Metals Trace | Lead ≤ 0.5 ppm, Arsenic ≤ 0.5 ppm, Cadmium ≤ 0.1 ppm | Inductively Coupled Plasma Mass Spectrometry (ICP-MS) | Eliminates neurotoxic contaminants derived from catalyst residues. |
Strategic overview of production clusters, fine-chemical distribution hubs, and regulatory cross-currents shaping the global LGD-4033 market.
Over 85% of commercial-scale raw LGD-4033 synthesis takes place within specialized fine-chemical clusters in East Asia, where advanced chiral synthesis, multi-step trifluoromethylation, and high-capacity cryo-reactors are economically optimized for multikilogram lot output.
International regulatory agencies (including US FDA, EMA, and WADA) have intensified oversight regarding non-steroidal selective androgen receptor modulators. Legitimate industrial suppliers focus strictly on reference standards, university bio-assays, and preclinical investigational markets.
The rise of mislabeled, sub-potent, or counterfeit batches in the global trade has created unprecedented market demand for dual-layer analytical verification: primary batch release Certificate of Analysis (COA) cross-verified with independent, domestic ISO/IEC 17025 laboratory data.
Where modern pharmacology and manufacturing chemistry intersect: the technological trends transforming SARM manufacturing and handling.
Continuous flow micro-reactors are steadily replacing batch vessels for hazardous trifluoromethylation steps, delivering superior heat dissipation, higher yields, and remarkably tighter stereoisomer ratios.
Factories are modernizing purification matrices, phasing out hazardous halogenated solvents in favor of recyclable ethanol-water recrystallization protocols to align with modern ESG supply requirements.
B2B contract buyers increasingly mandate customized particle size distribution (PSD d90 < 20μm) using specialized jet-milling equipment to guarantee superior dissolution and uniform suspension kinetics.
Tier-one factories are piloting immutable cryptographic batch hashes on physical containers, allowing end laboratories to verify the original batch COA against tamper-proof cloud-stored records.
In accordance with global compliance frameworks, high-purity LGD-4033 is strictly intended for scientific laboratory investigations, reference benchmarking, and pre-clinical in vitro/in vivo research.
Academic institutions and pharmaceutical laboratories utilize LGD-4033 reference material to benchmark selective androgen receptor affinity against non-selective steroidal controls in age-related sarcopenia and oncology-induced muscle wasting trials.
Investigations into osteoblast activity and cortical bone turnover evaluate Ligandrol's tissue selectivity. Quantitative bone histomorphometry models measure periosteal bone formation without adverse cross-stimulation of secondary sex organs.
Certified WADA-accredited testing facilities require pure reference LGD-4033 and its downstream di-hydroxy and glucuronide metabolites to calibrate Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS) screening equipment.
The manufacturing blueprint: how advanced chemical engineering is setting next-generation benchmarks for Ligandrol synthesis.
Integration of chiral organocatalysts during the pyrrolidine ring condensation stage. This innovation elevates optical purity to >99.5% enantiomeric excess (ee), minimizing undesired (S)-enantiomer synthesis from the outset.
Real-time Fourier Transform Infrared (FTIR) and focused beam reflectance measurement (FBRM) implementation directly within recrystallization tanks to control supersaturation curves and polymorphic stability.
Elimination of electrostatic agglomeration via proprietary inert-gas secondary drying tunnels, reducing Karl Fischer moisture content systematically below 0.2% for extended room-temperature shelf-life integrity.
Institutional procurement strategies designed to eliminate supply disruptions, customs confiscations, and analytical inconsistencies.
Direct shipment of micro-lots (1g to 5g) alongside blind split-lot testing. Enterprise contracts are executed only after independent secondary confirmation by accredited Western laboratories confirms spectral compliance.
Integrated documentation handling including complete SDS (Safety Data Sheets) formatted to GHS Rev.8, dual-language commercial invoices, HS code harmonization (2933.19), and clear Declaration of Non-Controlled Substance filings.
Bespoke contract syntheses for research consortia requiring custom batch packaging, specific vial fills (lyophilized or liquid formats), opaque amber glass protection, or nitrogen-flushed, vacuum-sealed multi-barrier foil pouches.
Authoritative technical, legal, and operational answers addressing the primary pain points in bulk LGD-4033 procurement.
Cross-category chemical syntheses manufactured under equivalent strict analytical parameters for laboratory and diagnostic applications.
